Sigma-Aldrich — Merger or Acquisition (September 2014)
55 slides from Sigma-Aldrich's merger presentation, Sep 22, 2014
Slide 1: Acquisition of Sigma-Aldrich
Acquisition of Sigma-Aldrich Taking Merck’s life science business to the next level Karl-Ludwig Kley, CEO Marcus Kuhnert, CFO M September 22, 2014
Slide 2: Disclaimer
M Disclaimer Publication of Merck KGaA, Darmstadt, Germany. In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany operate under the umbrella brand EMD.
Slide 3: Disclaimer: Cautionary Note Regarding Forward-Looking Statements
M Merck KGaA Darmstadt · Germany Disclaimer Cautionary Note Regarding Forward-Looking Statements This communication may include “forward-looking statements.” Statements that include words such as “anticipate,” “expect,” “should,” “would,” “intend,” “plan,” “project,” “seek,” “believe,” “will,” and o
Slide 4: Agenda
M Merck KGaA Darmstadt · Germany Agenda Strategic rationale and transaction overview Introduction of Sigma-Aldrich and the combined business Financial impacts Summary
Slide 5: Strategic agenda beyond 2014 – Focus on growth
M Merck KGaA Darmstadt · Germany Strategic agenda beyond 2014 – Focus on growth ~2012 - 2013 > 2014 Restructuring Growth initiatives Organic Inorganic Innovation Repatriation projects AZ Electronic Materials Potential pharma launches Early pipeline ramp-up Leverage regional platforms Sigma-Aldrich N
Slide 6: Sigma-Aldrich – Next step to enhance Merck Millipore
M Merck KGaA Darmstadt · Germany Sigma-Aldrich – Next step to enhance Merck Millipore, a leading life sciences company Attractive life science industry Attractive industry driven by sustainable underlying market trends Stable growth pattern, offering additional growth opportunities Strong companies
Slide 7: A compelling transaction rationale
M Merck KGaA Darmstadt · Germany A compelling transaction rationale Increasing scale – expanding position in attractive life science industry Enhancing value for our customers Strategic and operational fit Broadens product range and ease of doing business for Laboratories & Academia Complements Proc
Slide 8: Transaction overview
M Merck KGaA Darmstadt · Germany Transaction overview PRICE US$ 140 per share, all-cash offer PREMIUM Premium of 37% to unaffected share price; 36% to one-month volume-weighted average price (VWAP) CERTAINTY Recommended by Sigma-Aldrich Board of Directors; No Merck shareholder vote required FINANCIN
Slide 9: Agenda
M Merck KGaA Darmstadt · Germany Agenda Strategic rationale and transaction overview Introduction of Sigma-Aldrich and the combined business Financial impacts Summary
Slide 10: Sigma-Aldrich – A leading life science consumables supplier
M Merck KGaA Darmstadt · Germany Sigma-Aldrich – A leading life science consumables supplier Business Total revenues of $2.7 billion in 2013 ~9,000 employees including ~3,000 scientists and engineers Headquartered in St. Louis, MO Chemical and biochemical products, kits and services provider to labo
Slide 11: Merck and Sigma-Aldrich – Presenting a leading life science industry player
M Merck KGaA Darmstadt · Germany Merck and Sigma-Aldrich – Presenting a leading life science industry player Combined sales1 Laboratory & Academia ~€1.2 bn ~€1.1 bn ~€2.3 bn Bio-/Pharma production ~€1.1 bn ~€0.5 bn ~€1.6 bn ~€0.3 bn Other industries ~€0.5 bn ~€0.8 bn Merck Millipore Sigma-Aldrich Co
Slide 12: Sigma-Aldrich and Merck together serve the attractive €100bn life science industry
M Merck KGaA Darmstadt · Germany Sigma-Aldrich and Merck together serve the attractive €100bn life science industry Laboratory & Academia ~€25 bn industry Low-to-mid single digit growth Market trends Continued investments in pharma R&D Increased regulatory requirements for analytics and testing Emer
Slide 13: Broad and complementary product fit in attractive segments
M Merck KGaA Darmstadt · Germany Broad and complementary product fit in attractive segments Laboratory & Academia* Analytical standards Microbiology Antibodies Biochemicals Merck Millipore Sigma-Aldrich BioPharma production Upstream process Downstream process Buffers & media Bioreactors Chromatograp
Slide 14: Expanding global reach and scale
M Merck KGaA Darmstadt · Germany Expanding global reach and scale Global sales1 footprint of both businesses Emerging Markets2 Europe North America Rest of World3 Merck Millipore Sigma-Aldrich Combined Increased presence in North America Benefiting from a leading position in U.S. Laboratory sector I
Slide 15: Leveraging operational excellence to deliver superior value to customers
M Merck KGaA Darmstadt · Germany Leveraging operational excellence to deliver superior value to customers Delivering innovative workflow solutions to increase customers’ efficiency Product innovation Broad technology and platforms Recurring winners of renowned innovation awards Mobius FlexReady Duol
Slide 16: Agenda
M Merck KGaA Darmstadt · Germany Agenda Strategic rationale and transaction overview Introduction of Sigma-Aldrich and the combined business Financial impacts Summary
Slide 17: Sigma-Aldrich – Business and transaction financials
M Merck KGaA Darmstadt · Germany Sigma-Aldrich – Business and transaction financials Overview of financial data1 US$ m 2012 2013 2014E4 Revenue 2,623 2,704 2,796 % YoY at constant FX +3% +3% n.a. EBITDA (adjusted) 809 821 852 % of sales 31% 30% 30% D&A 136 138 132 % of sales 5% 5% 5% Net financial d
Slide 18: Transaction enhances Merck's financial profile
M Merck KGaA Darmstadt · Germany Transaction enhances Merck’s financial profile Merck - Pro-forma 20131 Sales EBITDA pre3 [€ bn] [€ bn] 14 19% 24% 5 12 4 10 8 79% 3 139% 6 2 4 1 2 0 0 Stand alone2 Merck with Sigma-Aldrich Stand alone2 Merck with Sigma-Aldrich Performance Materials Merck Millipore Co
Slide 19: Support from meaningful synergies
M Merck KGaA Darmstadt · Germany Support from meaningful synergies Merck experience Significant restructuring and integration experience Deep knowledge and understanding of the life science industry Source of synergies Consolidate manufacturing footprint Increase conversion to eCommerce channels Opt
Slide 20: Sigma-Aldrich acquisition – Financing secured
M Merck KGaA Darmstadt · Germany Sigma-Aldrich acquisition – Financing secured Net cash ~€13 bn ~€2 bn Sigma-Aldrich ~€4 bn ~€7 bn EV2 Equity value Take-out financing structure1 Cash Bank loans Bonds Financing details 100% cash and debt financed Bridge financing secured Final financing structure to
Slide 21: Agenda
M Merck KGaA Darmstadt · Germany Agenda Strategic rationale and transaction overview Introduction of Sigma-Aldrich and the combined business Financial impacts Summary
Slide 22: Sigma-Aldrich acquisition – Taking Merck Millipore to the next level
M Merck KGaA Darmstadt · Germany Sigma-Aldrich acquisition – Taking Merck Millipore to the next level Expanding position in the attractive life science industry, poised for sustainable growth Enhancing value for customers via strengthened offering, reach, and operational excellence Sigma-Aldrich and
Slide 23: M
M Merck KGaA Darmstadt · Germany
Slide 24: Appendix
M Merck KGaA Darmstadt · Germany Appendix
Slide 25: Indicative timeline of next steps
M Merck KGaA Darmstadt · Germany Indicative timeline of next steps Announcement (Sept. 22, 2014) Closing after: Regulatory filings Sigma-Aldrich shareholder approval at special meeting of shareholders Fulfillment of other customary closing conditions Closing (Expected mid-year 2015)
Slide 26: Investor Relations contact details
M Merck KGaA Darmstadt · Germany Investor Relations contact details Constantin Fest Head of Investor Relations +49 6151 72-5271 [email protected] Alessandra Heinz Assistant Investor Relations +49 6151 72-3321 [email protected] Svenja Bundschuh Assistant Investor Relations
Slide 27: Media Relations contact details
M Merck KGaA Darmstadt · Germany Media Relations contact details Dr. Walter Huber Head of Group Communications +49 6151 72-2287 [email protected] Nicole Mommsen Head of Media Relations +49 6151 72-62445 [email protected] Silke Klotz Assistant Media Relations +49 6151 72-4342 si
Slide 28: Merck and Merck Millipore Townhall
M Merck KGaA Darmstadt · Germany Merck and Merck Millipore Townhall Announced Sigma-Aldrich acquisition Taking our life science business to the next level September 22, 2014 Bernd Reckmann, Member of the Merck Executive Board, Head of Chemicals Udit Batra, President & CEO, Merck Millipore 1
Slide 29: Disclaimer: Cautionary Note Regarding Forward-Looking Statements
M Merck KGaA Darmstadt · Germany Disclaimer Cautionary Note Regarding Forward-Looking Statements This communication may include “forward-looking statements.” Statements that include words such as “anticipate,” “expect,” “should,” “would,” “intend,” “plan,” “project,” “seek,” “believe,” “will,” and o
Slide 30: Content for today
M Merck KGaA Darmstadt · Germany Content for today Today’s News Highlights The Combination: Fits Our Strategy What is Our Responsibility Now? 3
Slide 31: Content for today
M Merck KGaA Darmstadt · Germany Content for today Today’s News Highlights The Combination: Fits Our Strategy What is Our Responsibility Now? 4
Slide 32: Strategic agenda beyond 2014 – Focus on growth
M Merck KGaA Darmstadt · Germany Strategic agenda beyond 2014 – Focus on growth ~2012 - 2013 > 2014 Restructuring Growth initiatives Organic Inorganic Innovation Repatriation projects AZ Electronic Materials Potential pharma launches Early pipeline ramp-up Leverage regional New advanced platforms Si
Slide 33: Sigma-Aldrich – Next step to enhance Merck's position
M Merck KGaA Darmstadt · Germany Sigma-Aldrich – Next step to enhance Merck’s position in attractive life science industry Attractive life science industry Attractive industry driven by sustainable underlying market trends Stable growth pattern, offering additional growth opportunities Strong compan
Slide 34: Sigma-Aldrich – A leading life science and technology company
M Merck KGaA Darmstadt · Germany Sigma-Aldrich – A leading life science and technology company Business overview Total revenues of $2.7 billion in 2013 ~9,000 employees including ~3,000 scientists and engineers Headquartered in St. Louis, MO Chemical and biochemical products, kits and services provi
Slide 35: Transaction overview
M Merck KGaA Darmstadt · Germany Transaction overview Price US$ 140 per share, all-cash offer Premium Premium of 37% over unaffected share price; 36% over one- month volume-weighted average price (VWAP) Certainty Recommended by Sigma-Aldrich Board of Directors; No Merck shareholder vote required Bri
Slide 36: Sigma-Aldrich – Business and transaction financials
M Merck KGaA Darmstadt · Germany Sigma-Aldrich – Business and transaction financials Overview of financial data1 US$ m 2012 2013 2014E4 Revenue 2,623 2,704 2,796 % YoY at constant FX +3% +3% n.a. EBITDA (adjusted) 809 821 852 % of sales 31% 30% 30% D&A 136 138 132 % of sales 5% 5% 5% Net financial d
Slide 37: Transaction enhances Merck's financial profile
M Merck KGaA Darmstadt · Germany Transaction enhances Merck’s financial profile Merck - Pro-forma 20131 Sales EBITDA pre3 [€ bn] [€ bn] 14 19% 5 24% 12 4 10 8 79% 3 139% 6 2 4 1 2 0 0 Stand alone2 Merck with Stand alone2 Merck with Sigma-Aldrich Sigma-Aldrich Performance Materials Merck Millipore Co
Slide 38: A compelling transaction rationale
M Merck KGaA Darmstadt · Germany A compelling transaction rationale Strategic and operational fit Increasing scale – growing position in attractive life science industry Enhancing value for our customers – Broadens product range and ease of doing business for Laboratory & Academia – Complements Proc
Slide 39: Content for today
M Merck KGaA Darmstadt · Germany Content for today Today’s News Highlights The Combination: Fits Our Strategy What is Our Responsibility Now? 12
Slide 40: Let's reflect back on the strategy… Life science: An attractive market
M Merck KGaA Darmstadt · Germany Let’s reflect back on the strategy… Life science: An attractive market Growing Market €Bn Process Labs +5% +5% 29 34 39 9 7% 11 7% 14 Process Process Process 20 4% 23 4% 25 Labs Labs Labs 2011 2014 2017 Can Be Highly Profitable EBIT+A, % of revenue* Waters 31 Sigma 3
Slide 41: We also understood what was needed to succeed in the marketplace
M Merck KGaA Darmstadt · Germany We also understood what was needed to succeed in the marketplace Labs 1. Broad and attractive product offering 2. Simple customer interface 3. Organization able to deal with complexity Process 1. Deeply technical field force 2. Product depth in developed markets 3. B
Slide 42: Global geographic footprint with opportunity in NA for Labs
M Merck KGaA Darmstadt · Germany Global geographic footprint with opportunity in NA for Labs Labs Opportunity in NA €1.5B €22B Merck Millipore Market NA ROW 15
Slide 43: Broad and complementary product fit in attractive segments
M Merck KGaA Darmstadt · Germany Broad and complementary product fit in attractive segments Laboratory & Academia* Analytical standards Microbiology Antibodies Biochemicals Merck Millipore Sigma-Aldrich Bio-/Pharma production Upstream process Downstream process Buffers & media Bioreactors Chromatogr
Slide 44: Leverage operational excellence to deliver superior value to customers
M Merck KGaA Darmstadt · Germany Leverage operational excellence to deliver superior value to customers Product innovation Delivering innovative workflow solutions to increase customers’ efficiency Broad technology and platforms Recurring winners of renowned innovation awards Mobius FlexReady CellAS
Slide 45: Combining two leading life science companies
M Merck KGaA Darmstadt · Germany Combining two leading life science companies >4% sales CAGR each 24% EBITDA 30% EBITDA 1 million Customers each >300K total products Over 9,000 employees each ~600 R&D team ~500 PhDs 10+ top R&D awards 6% of sales in R&D #1 e-commerce 24-hour delivery Merck Millipore
Slide 46: Commitment to our local communities
M Merck KGaA Darmstadt · Germany Commitment to our local communities Merck/Merck Millipore Sigma-Aldrich Habitat for Humanity Greater Boston World Health Organization GPHF GLOBAL PHARMA HEALTH FUND E.V. RESPONSIBLE CARE® OUR COMMITMENT TO SUSTAINABILITY Midleton College Spartam Nactus Es Hanc Exorna
Slide 47: Merck and Sigma-Aldrich – Presenting a leading life science industry player
M Merck KGaA Darmstadt · Germany Merck and Sigma-Aldrich – Presenting a leading life science industry player Combined sales1 Laboratory & Academia ~€1.2bn ~€1.1bn ~€ 2.3bn Bio-/Pharma production ~€1.1bn ~€0.5bn ~€ 1.6bn ~€0.3bn Other industries ~€0.5bn ~€ 0.8bn Merck Millipore Sigma-Aldrich Combined
Slide 48: Support from meaningful synergies
M Merck KGaA Darmstadt · Germany Support from meaningful synergies Merck experience Significant restructuring and integration experience Deep knowledge and understanding of the life science industry Source of synergies Consolidate manufacturing footprint Increase conversion to e-commerce channels Op
Slide 49: Sigma-Aldrich acquisition takes Merck Millipore to the next level
M Merck KGaA Darmstadt · Germany Sigma-Aldrich acquisition takes Merck Millipore to the next level Expanding position in attractive life science industry, poised for sustainable growth Enhancing value for customers via strengthened offering, reach and operational excellence Sigma-Aldrich and Merck M
Slide 50: Content for today
M Merck KGaA Darmstadt · Germany Content for today Today’s News Highlights The Combination: Fits Our Strategy What is Our Responsibility Now? 23
Slide 51: Next steps on deal
M Merck KGaA Darmstadt · Germany Next steps on deal Agreed transaction has been announced but will not close until mid-year 2015 Kick off integration plan with a subset of team members Minimize disruption to both organizations & customers until we close deal 24
Slide 52: Our Merck Millipore responsibility now
M Merck KGaA Darmstadt · Germany Our Merck Millipore responsibility now Customers, Customers, Customers Deliver Performance: Close Q3 & FY2014 Avoid Assumptions 25
Slide 53: Our Merck responsibility now
M Merck KGaA Darmstadt · Germany Our Merck responsibility now Business as usual Close the transaction in mid-year 2015 Focus on growth opportunities across all businesses 26
Slide 54: Taking Merck to the next level
M Merck KGaA Darmstadt · Germany Taking Merck to the next level In Line with the Group Strategy Beneficial Diversification of Revenues and Sustainable Profitability More Choice for More Customers Product and Process innovation – operational excellence & e-commerce) 27
Slide 55: Questions & Answers
CONFIDENTIAL – FOR INTERNAL USE ONLY Questions & Answers
Sigma Aldrich — Merger or Acquisition (September 2014) on 6ix